Left ventricular hypertrophy (LVH) is an independent risk factor for cardiac mortality in adults
with end-stage renal disease (ESRD). It is prevalent in pediatric patients on chronic dialysis …

Left ventricular hypertrophy (LVH) has been recognized as an independent risk factor for
cardiovascular morbidity and mortality in adults with end-stage renal disease. However, the …

Cross-sectional studies have demonstrated that left ventricular hypertrophy (LVH) is
common in children on maintenance dialysis. We report the echocardiogram results of 17 …

Left ventricular hypertrophy (LVH) is related to a 1,000-fold increased risk of cardiovascular
morbidity and mortality in young adults with end-stage renal disease (ESRD) treated with …

Background Left ventricular mass index (LVMI) is a surrogate of left ventricular hypertrophy
and a predictor of cardiac morbidity and mortality in adults with hypertension. LVMI has not …

Background Cardiovascular disease (CVD) is a common cause of morbidity and mortality in
children with chronic kidney disease (CKD). Left ventricular hypertrophy (LVH) and diastolic …

Aims Patients with chronic kidney disease are at high risk of cardiovascular morbidity and
mortality. Increased left ventricular mass (LVM) has been shown to be an adverse prognostic …

Left ventricular hypertrophy (LVH) is the most important independent marker of
cardiovascular risk in adults with chronic kidney disease. Cardiovascular morbidity seems …

Left ventricular hypertrophy (LVH) is a risk factor for cardiovascular disease, and it is
prevalent in children with end-stage renal disease (ESRD) and after renal transplantation …

OBJECTIVE: To determine the prevalence and incidence of left ventricular hypertrophy
(LVH) and LV geometry and identify variables associated with LV mass (LVM) growth and …